Related Experiment Video
Updated: Apr 4, 2026
04:49
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
2.0K
Bidirectional and Multivariable Mendelian Randomization Study of PCOS and VTE.
Lifang You1, Hongyin Cui1, Fen Zhao1
1Department of Gynecology and Obstetrics, First People's Hospital of Linping District, Hangzhou, 311100, People's Republic of China.
International Journal of Women'S Health
|April 3, 2026
Summary
Genetic analysis found no causal link between polycystic ovary syndrome (PCOS) and venous thromboembolism (VTE). Body mass index (BMI) showed an independent association with increased VTE risk, suggesting it is a key factor.
Area of Science:
- Genetics
- Epidemiology
- Metabolic Disorders
Background:
- Polycystic ovary syndrome (PCOS) is a common endocrine disorder.
- Venous thromboembolism (VTE) is a significant cause of morbidity and mortality.
- The potential causal relationship between PCOS and VTE requires investigation.
Purpose of the Study:
- To investigate the causal relationship between polycystic ovary syndrome (PCOS) and venous thromboembolism (VTE) using Mendelian randomization.
- To assess the causal effect in both directions: PCOS influencing VTE and VTE influencing PCOS.
Main Methods:
- Bidirectional two-sample Mendelian randomization (MR) analysis was employed.
- European-ancestry Genome-Wide Association Studies (GWAS) summary statistics were utilized.
- Multivariable MR adjusted for key confounders including BMI, diabetes, and hormone use.
Main Results:
- Univariable and multivariable MR analyses found no evidence of a causal effect of PCOS on VTE.
- Reverse MR analysis also showed no causal influence of VTE on PCOS.
- Body mass index (BMI) demonstrated a significant independent positive association with VTE risk.
Conclusions:
- Current genetic evidence does not support a causal link between PCOS and VTE.
- BMI is an independent determinant of VTE risk.
- Further research may explore the role of BMI in the PCOS-VTE association.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
439
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
439
01:30Venous Thrombosis I: Introduction
700
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
700
01:29Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
01:13Randomized Experiments
9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
9.3K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
112
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
112
01:09Odds Ratio
2.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.3K